Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-16-021564)

Filing Details

Accession Number:: 0000899243-16-021564
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-02 21:38:17
Reporting Period:: 2016-06-01

Filing Date:: 2016-06-02
Accepted Time:: 2016-06-02 21:38:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1609809	Seres Therapeutics Inc.	MCRB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1233684	N David Cook	C/O Seres Therapeutics, Inc. 200 Sidney Street Cambridge MA 02139	Chief Scientific Officer & Evp	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-06-01	16,000	$29.43	144,673	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2016.